Overview Rifaximin Treatment of Papulopustular Rosacea Status: Withdrawn Trial end date: 2014-12-01 Target enrollment: Participant gender: Summary The purpose of this study is to determine the effects of rifaximin on skin symptoms in patients with rosacea by double-blinded, placebo-controlled, crossover study. Phase: Phase 2 Details Lead Sponsor: University of California, San FranciscoTreatments: RifamycinsRifaximin